companydata.dkcompanydata.dk

NUEVOLUTION A/S: Financial statements 2023

CVR: 26029708

Source: annual report 2023, Danish Business Authority

01/01/202331/12/2023

NUEVOLUTION A/S (CVR 26029708) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 77,164,000 and a net result of DKK -36,208,000 compared with DKK -28,120,000 the year before. That is an increase of 12.7% compared with the year before. The profit margin was -46.9%. Equity in the 2023 report amounted to DKK 68,122,000. The solvency ratio was 51.9%. The company had 69 employees in the financial year.

Revenue
DKK 77,164,000
Profit/Loss
DKK -36,208,000
Equity
DKK 68,122,000
Total Assets
DKK 131,377,000
Employees
69

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
202377.2 mio.--36.2 mio.68.1 mio.69
202268.5 mio.--28.1 mio.104.3 mio.63
2021162.3 mio.-63 mio.132.4 mio.56
202037 mio.--33.5 mio.69.5 mio.54
201917.4 mio.--76.3 mio.1.8 mio.49

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Registered as owner of NUEVOLUTION A/SNov 15, 2023

As of November 15, 2023, is registered as an owner of NUEVOLUTION A/S with an ownership share of 100%.

NUEVOLUTION A/S: The 2022 annual report is outJul 5, 2023

NUEVOLUTION A/S has published its annual report for 2022. Revenue came to DKK 68,498,000, and the net result was DKK -28,120,000.

About NUEVOLUTION A/S

NUEVOLUTION A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 2001. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named CHEMGENE ApS. The management consists of Thomas Franch. The board consists of Tore von Würden Petersen (chair), Jeffrey David Bernd and Omari Clinton Wise. The company is owned by Amgen, Inc.. The company has 59 employees (2018). In 2025, the company reported revenue of DKK 203,323,000 and a net result of DKK 39,754,000 compared with DKK -18,383,000 the year before. Equity in the 2025 report amounted to DKK 89,493,000.

Source: annual report 2025, Danish Business Authority